ClinicalTrials.govpublic full text
Cognition and MRI Markers in MS Patients With Aubagio® Treatment
multiple sclerosis, relapsing-remitting, autoimmune diseases of the nervous system, demyelinating autoimmune diseases, cns, demyelinating diseases, immune system diseases, nervous system diseases, pathologic processes, cognitive impairment, ecological assessment, brain mri, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872049
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.